Skip to content

A human study to evaluate safety and effectiveness of Perilla oil on blood flow

A human study to evaluate safety and effectiveness of Perilla oil on blood flow

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009442
Enrollment
80
Registered
2024-05-17
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Seoul National University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Man and women (19 years = Age < 70 years) 2) Smoker

Exclusion criteria

Exclusion criteria: 1) Volunteer who has taken drugs or healthy functional food affecting lipid metabolism, platelet function, or coagulation reactions within a month before the first visit. 2) Following diseases : Dyslipidemia, platelet dysfunction, etc. 3) Volunteer who consumes a large amount of foods rich in omega-3 fatty acids. 4) Volunteer who has recently experienced a weight change or is on a diet for weight control. 5) Excessive exercise 6) Volunteer who drink continuously 7) Volunteer who has been in clinical demonstration within 1 month 8) Pregnant woman, lactating women or planning to pregnant 9) Volunteer who are hypersensitivity or allergy to dietary supplement or ingredients contained in the supplement. 10) Volunteer who judged incongruent by tester through clinical examination center

Design outcomes

Primary

MeasureTime frame
Platelet aggregation, blood coagulation, fibrinolysis, blood lipid profile

Secondary

MeasureTime frame
Adverse reaction, vital signs

Countries

Korea, Republic of

Contacts

Public ContactMin Ju Park

Seoul National University of Science and Technology

alswn1895@seoultech.ac.kr+82-2-974-6740

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026